Insider · CIK 0002087548
Christopher Ryan Cave Barrett
Files at ATAI (ATAI Life Sciences N.V.), ATAI (AtaiBeckley Inc.). First filing -, latest -.
In brief
Christopher Ryan Cave Barrett files SEC Form 4 as officer at ATAI (ATAI Life Sciences N.V.), and also at ATAI (AtaiBeckley Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher Ryan Cave Barrett has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Common Stock | -155,066 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -347,000 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -284,832 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -231,900 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -71,620 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -400,000 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -550,000 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -757,915 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -175,000 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -675,000 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -150,000 | - | - | 0 | 34 d ago |
| Jan 30, 2026 | ATAI AtaiBeckley Inc. | AGrant or award Stock Optionderivative | +675,000 | $0.00 | $0 | 675,000 | Feb 3, 2026 |
| Jan 30, 2026 | ATAI AtaiBeckley Inc. | AGrant or award Restricted Stock Unitsderivative | +150,000 | $0.00 | $0 | 150,000 | Feb 3, 2026 |
| Oct 1, 2025 | ATAI ATAI Life Sciences N.V. | AGrant or award Stock Optionderivative | +175,000 | $0.00 | $0 | 175,000 | Oct 3, 2025 |
Questions about Christopher Ryan Cave Barrett
Answered from the filings on this page, as of the latest one.
Is Christopher Ryan Cave Barrett buying or selling?
Christopher Ryan Cave Barrett has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher Ryan Cave Barrett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher Ryan Cave Barrett has 0.
Where does Christopher Ryan Cave Barrett file Form 4?
Christopher Ryan Cave Barrett has filed Form 4 at ATAI (ATAI Life Sciences N.V.) as See Remarks; ATAI (AtaiBeckley Inc.) as See remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.